Martingale Asset Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.55M Sell
15,843
-955
-6% -$274K 0.11% 159
2025
Q1
$5.18M Sell
16,798
-17,854
-52% -$5.5M 0.13% 152
2024
Q4
$12.2M Sell
34,652
-2,450
-7% -$864K 0.3% 112
2024
Q3
$13.3M Sell
37,102
-5,664
-13% -$2.03M 0.31% 109
2024
Q2
$13.6M Sell
42,766
-5,537
-11% -$1.76M 0.29% 116
2024
Q1
$11.1M Sell
48,303
-7,525
-13% -$1.73M 0.22% 131
2023
Q4
$12.3M Sell
55,828
-250
-0.4% -$55K 0.25% 124
2023
Q3
$12.7M Sell
56,078
-3,990
-7% -$901K 0.27% 119
2023
Q2
$13.3M Sell
60,068
-2,936
-5% -$648K 0.26% 123
2023
Q1
$14.1M Buy
63,004
+1,761
+3% +$394K 0.27% 133
2022
Q4
$17M Sell
61,243
-2,022
-3% -$562K 0.33% 120
2022
Q3
$13.2M Buy
63,265
+8,140
+15% +$1.7M 0.26% 128
2022
Q2
$13M Buy
55,125
+6,307
+13% +$1.49M 0.24% 127
2022
Q1
$8.76M Buy
48,818
+12,434
+34% +$2.23M 0.13% 160
2021
Q4
$7.86M Buy
36,384
+28,944
+389% +$6.26M 0.1% 168
2021
Q3
$1.37M Sell
7,440
-81,937
-92% -$15.1M 0.02% 425
2021
Q2
$16M Sell
89,377
-6,694
-7% -$1.2M 0.18% 154
2021
Q1
$16.1M Buy
96,071
+30,160
+46% +$5.05M 0.18% 154
2020
Q4
$10M Buy
65,911
+23,602
+56% +$3.58M 0.11% 177
2020
Q3
$4.28M Buy
42,309
+27,976
+195% +$2.83M 0.05% 241
2020
Q2
$1.74M Buy
+14,333
New +$1.74M 0.02% 576
2015
Q4
Sell
-1,806
Closed -$238K 879
2015
Q3
$238K Hold
1,806
0.01% 782
2015
Q2
$315K Buy
1,806
+1
+0.1% +$174 0.01% 767
2015
Q1
$312K Buy
+1,805
New +$312K 0.01% 782
2014
Q4
Sell
-1,607
Closed -$207K 887
2014
Q3
$207K Buy
+1,607
New +$207K 0.01% 821